Corticotropin-releasing hormone (CRH) neurons of the hypothalamic paraventricular nucleus (PVN) are the central orchestrators of the mammalian stress response. These neuroendocrine cells integrate diverse stress signals and initiate the hypothalamic-pituitary-adrenal (HPA) axis cascade, resulting in glucocorticoid release from the adrenal cortex. Dysregulation of CRH neurons underlies multiple stress-related psychiatric disorders and contributes to neurodegeneration in Alzheimer's disease, Parkinson's disease, and related conditions.[1][2]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4042028 | immature neuron |
CRH neurons are concentrated in the parvocellular division of the PVN, a midline hypothalamic nucleus adjacent to the third ventricle. The PVN contains three major neuronal populations:
| Population | Location | Function |
|---|---|---|
| Parvocellular CRH | Dorsal medial | HPA axis activation |
| Parvocellular AVP | Dorsal | HPA axis potentiation |
| Magnocellular OT/AVP | Lateral | Posterior pituitary secretion |
CRH neurons receive convergent input from:
| Gene | Product | Function |
|---|---|---|
| CRH | Corticotropin-releasing hormone | ACTH secretagogue |
| AVP | Arginine vasopressin | ACTH potentiation |
| NR3C1 | Glucocorticoid receptor | Negative feedback |
| MR | Mineralocorticoid receptor | Basal HPA tone |
| FKBP5 | FK506-binding protein 51 | GR sensitivity regulation |
CRH is synthesized as a 196-amino acid preprohormone, cleaved to a 41-amino acid active peptide. Synthesis is regulated by:
CRH acts through two G-protein coupled receptors:
| Receptor | Distribution | Function |
|---|---|---|
| CRHR1 | Pituitary, cortex, amygdala | ACTH release, anxiety |
| CRHR2 | Hypothalamus, lateral septum | Stress recovery, anxiolysis |
CRH binds CRHR1 with higher affinity, while urocortins preferentially activate CRHR2. This receptor distribution creates spatial and temporal specificity in stress responses.[5]
The HPA axis exhibits pronounced diurnal variation:
CRH neuron activity follows this rhythm via SCN input, with stressors superimposed on the baseline pattern.[6]
CRH hypersecretion is consistently observed in depression:
PTSD shows distinct CRH alterations:
CRH neurons are vulnerable in AD:
Chronic HPA activation accelerates AD pathology through:
The cortisol-tau pathway connects chronic stress to tau pathology:
CRH neurons and the immune system engage in bidirectional communication:
In AD and PD, chronic neuroinflammation creates a feed-forward loop:
Multiple CRHR1 antagonists have been developed:
| Compound | Development Status | Indication |
|---|---|---|
| Pexacerfont | Phase III failed | GAD |
| Verucerfont | Phase II terminated | Depression |
| GSK561679 | Phase II | PTSD |
| Emicerfont | Preclinical | Alcohol withdrawal |
Limited clinical success reflects the complexity of modulating stress circuits without disrupting essential homeostatic functions.[12]
Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213(4514):1394-1397. https://doi.org/10.1126/science.6267699. 1981. ↩︎
Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005;4(2):141-194. https://doi.org/10.1016/j.arr.2005.01.003. 2005. ↩︎
Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10(6):397-409. https://doi.org/10.1038/nrn2647. 2009. ↩︎
Aguilera G. HPA axis responsiveness to stress: implications for healthy aging. Exp Gerontol. 2011;46(2-3):90-95. https://doi.org/10.1016/j.exger.2010.08.023. 2011. ↩︎
Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol. 2004;44:525-557. https://doi.org/10.1146/annurev.pharmtox.44.101802.121410. 2004. ↩︎
Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010;11(10):710-718. https://doi.org/10.1038/nrn2914. 2010. ↩︎
Holsboer F. Stress, hormones, and depression. Dialogues Clin Neurosci. 2010;12(1):23-29. https://pubmed.ncbi.nlm.nih.gov/20195862/. 2010. ↩︎
Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiatry. 2001;62 Suppl 17:41-46. https://pubmed.ncbi.nlm.nih.gov/11495094/. 2001. ↩︎
Notman MT, Nadeau JH, Hohmann C. Hypothalamic-pituitary-adrenal axis dysregulation in Alzheimers disease. Curr Alzheimer Res. 2021;18(6):453-465. https://doi.org/10.2174/1567205018666210906143217. 2021. ↩︎
Videnovic A, Noble C, Reid KJ, et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 2014;71(4):463-469. https://doi.org/10.1001/jamaneurol.2013.6239. 2014. ↩︎
Munhoz CD, Sorrells SF, Caso JR, et al. Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus. Neurobiol Dis. 2010;37(1):63-74. https://doi.org/10.1016/j.nbd.2009.09.013. 2010. ↩︎
Zorrilla EP, Koob GF. Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov Today. 2010;15(9-10):371-383. https://doi.org/10.1016/j.drudis.2010.02.011. 2010. ↩︎